# FDA recall D-1453-2016

> **Teva North America** · Class III · drug recall initiated 2016-07-15.

## Product

Children's Qnasl 40 mcg (beclomethasone dipropionate) Nasal Aerosol, 40 mcg per spray, 60 Metered Sprays per canister, 4.9g Net Contents, Rx only; Professional Sample; Manufactured for Teva Respiratory, LLC, Horsham, PA  19044; By: 3M Drug Delivery Systems, Northridge, CA  91324; NDC 59310-206-08.

## Reason for recall

Failed Content Uniformity Specifications: out of specification test result for spray content uniformity.

## Distribution

Nationwide

## Key facts

- **Recall number:** D-1453-2016
- **Recalling firm:** Teva North America
- **Classification:** Class III
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2016-07-15
- **Report date:** 2016-08-10
- **Termination date:** 2017-03-10

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Horsham, PA, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1453-2016

## Citation

> AI Analytics. FDA recall D-1453-2016. Retrieved 2026-05-25 from https://api.ai-analytics.org/recall/D-1453-2016. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*